GP2 and Cowden disease: Association between pancreatic antibodies and extraintestinal manifestation of CD was described by Lakatos et al. [31] and we also have confirmed higher levels of anti-GP2 IgA in CD patients, who have had an extraintestinal manifestation of the disease, however no statistically significant difference was noted.